Skip to main content
. 2021 Nov;42(6):515–521. doi: 10.2500/aap.2021.42.210075

Table 1.

Characteristics and demographics of the patients who presented to the allergy and immunology clinic with presumed allergic reactions to the first dose of COVID-19 messenger RNA vaccine (N = 77)

graphic file with name OC-AAPJ210075T001.jpg

COVID-19 = Coronavirus disease 2019.

*A COVID-19 diagnosis based on laboratory confirmed results or self-report.

#Hydroxychloroquine (n = 2), rituximab and prednisone (n = 1), tofacitinib (n = 1), ustekinumab (n = 1), adalimumab (n = 1).